A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children's Oncology Group
儿童肿瘤协作组报告:RANKL抗体地诺单抗治疗复发/难治性骨肉瘤两组患者的II期临床试验
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-2885
Janeway, Katherine A; Chou, Alexander J; Buxton, Allen; Reid, Joel; Isakoff, Michael S; Kopp, Lisa; Hingorani, Pooja; Lee, Jill L; Doski, John; Daldrup-Link, Heike; Hall, Laura; Randall, R Lor; Reed, Damon R; Dubois, Steven G; Krailo, Mark; Grier, Holcombe; Gorlick, Richard